Shanghai Fosun Pharmaceutical subsidiary Oxazepam tablets received drug registration approval.

Shanghai Fosun Pharmaceutical (600196.SH) announced that the application for the listing registration of its subsidiary, Hunan Dongting Pharmaceutical Co., Ltd.'s oxazepam tablets (referred to as "the drug"), has recently been approved by the National Medical Products Administration. The drug is a chemical drug independently developed by the group (i.e. the company and its controlling subsidiaries/units). The drug is mainly used for short-term relief of anxiety, tension, agitation, and can also be used for hypnotic purposes. It is also used as an adjunct therapy for anxiety accompanied by mental depression, and can alleviate acute alcohol withdrawal symptoms.